Literature DB >> 10774693

Prevalence of hepatitis a antibodies in western Indian population: changing pattern.

S D Chitambar1, M S Chadha, M S Joshi, V A Arankalle.   

Abstract

This report pertains to a retrospective study conducted between 1983 and 1995 at three time points to evaluate the prevalence of hepatitis A virus (HAV) infection in the population of Bhor Taluk, situated in western India. Serum samples from children and adults were tested for anti-HAV antibodies using blocking ELISA test. There was a significant decrease in anti-HAV prevalence among children aged 5-10 years in 1995 (87.36%) as compared to that of 1983 (97.58%) and 1987 (96.48%). All individuals >11 years of age were seropositive for anti-HAV antibodies. Anti-HAV prevalence was similar in the users of well water, but was significantly reduced in individuals supplied with piped water in 1995 (88.61%) compared with that in 1983 (98.77%). A significant decrease in anti-HAV positivity was noted in children from Bhor Taluk as compared to children from Pune bled in 1992. These results underline the need for periodic surveillance of seroepidemiology of hepatitis A to determine the measures for prevention and control of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10774693

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

1.  Seroepidemiology of hepatitis A in voluntary blood donors from Pune, western India (2002 and 2004-2005).

Authors:  P S Gadgil; R S Fadnis; M S Joshi; P S Rao; S D Chitambar
Journal:  Epidemiol Infect       Date:  2007-06-07       Impact factor: 2.451

2.  Hepatitis A vaccine should receive priority in National Immunization Schedule in India.

Authors:  Ramesh Verma; Pardeep Khanna
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 3.  Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.

Authors:  Ziba Farajzadegan; Shervin Ghaffari Hoseini; Roya Kelishadi; Fahimeh Jamshidi; Zari Nokhodian; Rasool Noori; Parisa Mirmoghtadaee; Silva Hovsepian; Seyyed-Nassereddin Mostafavi
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

Review 4.  A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children.

Authors:  Sameer Rao; J S Mao; Salman Motlekar; Zhuang Fangcheng; Ganesh Kadhe
Journal:  Hum Vaccin Immunother       Date:  2016-12       Impact factor: 3.452

5.  Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India.

Authors:  Bhaskar Raju; Anar Andani; Shafi Kolhapure; Ashish Agrawal
Journal:  Hum Vaccin Immunother       Date:  2020-11-25       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.